Pfizer predicts $54bn in 2022 revenue from Comirnaty and Paxlovid
Pfizer forecasts $32bn in revenue for COVID-19 vaccine Comirnaty, and $22bn for oral COVID-19 treatment Paxlovid, in 2022.
Archives for February 8, 2022
Salipro Biotech gains European patent for antigen production
Swedish company Salipro Biotech has been granted a patent in Europe for its novel antigen technology.
US adds WuXi Biologics subsidiaries to ‘unverified list’ of exporters
WuXi Biologics Cayman Inc suspended trading of its Hong Kong shares today after its inclusion of two of its units on the US government’s so-called unverified list of exporters triggered a record selloff, noted financial media outlets.
Oxford Biomedica signs spate of partnership deals
The company announces two deals, marking a busy month with four partnerships for its lentiviral vector technology.
WCG: Consider IBC review requirements early on in HGT clinical trial planning
Planning for Institutional Biosafety Committee (IBC) oversight is a critical and often neglected initiation step for human gene transfer (HGT) clinical research, says an expert.